OakChart

Tandem Diabetes Care Inc

TNDMHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 11:15 AM ET

19.45+0.74 (3.96%)
2026-11-11 17:15 CET
Market cap
1,305.84 USD m
Revenue, TTM
1,074.78 USD m
Net income, TTM
-49.23 USD m
Free cash flow, TTM
-36.30 USD m
EPS diluted, TTM
-0.72
P/E
-
Compare

Price

TNDM against its 20, 50 and 200-day averages
2050200beat
15.0020.0025.003.8M7.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TNDMclose 19.4520-day 17.9950-day 17.48200-day 18.8519.4552w low

34.4% under the 52-week high of 29.65 on 24 Feb 2026. 52-week low 12.26 on 15 May 2026. Last 15 sessions, 31.1% high to low

Profile

TNDM
52-week range, 41% of the way up
12.2629.65

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

IndexRUT
Employees2500
IPONov 14, 2013
Beta1.59
ATR, 14d1.23
Rel volume0.56
Short float23.46%
Insider own1.24%
Inst own115.22%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.36B
Enterprise Value1.65B
Income-49.23M
Sales1.07B
Book/sh1.94
Cash/sh6.35
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees2500
IPONov 14, 2013

Ratios

P/E-
Forward P/E445.49
PEG-
P/S1.26
P/B10.04
P/C3.06
P/FCF-
EV/EBITDA-
EV/Sales1.54
Quick Ratio2.65
Current Ratio3.21
Debt/Eq5.45
LT Debt/Eq5.30
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.72
EPS next Y0.04
EPS next Q0.10
EPS this Y58.60%
EPS next Y107.23%
EPS next 5Y-
EPS past 3/5Y-27.30% -40.10%
Sales past 3/5Y8.22% 15.27%
EPS Y/Y TTM76.54%
Sales Y/Y TTM6.73%
EPS Q/Q67.49%
Sales Q/Q13.55%
EarningsNov 05 AMC
EPS/Sales Surpr.58.54% 6.71%

Ownership

Insider Own1.24%
Insider Trans-0.20%
Inst Own115.22%
Inst Trans0.49%
ROA-4.84%
ROE-36.74%
ROIC-5.78%
Gross Margin56.60%
Oper. Margin-2.45%
Profit Margin-4.58%
SMA208.09%
SMA5011.26%
SMA2003.19%
Trades-

Technical

Shs Outstand69.76M
Shs Float68.93M
Short Float23.46%
Short Ratio7.57
Short Interest16.17M
52W High29.65 -34.40%
52W Low12.26 58.65%
Volatility9.79% 6.56%
ATR (14)1.23
RSI (14)58.48
Beta1.59
Rel Volume0.56
Avg Volume2.14M
Volume367,459

Performance

Perf Week2.10%
Perf Month16.82%
Perf Quarter-15.91%
Perf Half Y37.85%
Perf YTD-11.51%
Perf Year11.02%
Perf 3Y36.20%
Perf 5Y-85.49%
Perf 10Y8.06%
Recom2.00
Target Price27.25
Prev Close18.71
Price19.45
Change %3.96%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 07, 2026InitiatedBBarclaysEqual Weight$18-7.5%
Sep 30, 2026ReiteratedCCitigroupNeutral$24 → $20+2.8%
Aug 21, 2026InitiatedWWilliam BlairOutperform
Jul 28, 2026ResumedUUBSNeutral$18-7.5%
Jun 23, 2026InitiatedDDeutsche BankHold$15.50-20.3%
Jun 01, 2026UpgradeWWells FargoEqual Weight → Overweight$27+38.8%
May 12, 2026InitiatedTThe Benchmark CompanyHold
Mar 19, 2026UpgradeTTruistHold → Buy$35+79.9%
Mar 17, 2026UpgradePPiper SandlerNeutral → Overweight$33+69.7%
Feb 23, 2026UpgradeLLake StreetHold → Buy$50+157.1%

Peers

Mkt cap
TickerCompanyMkt cap
PODDInsulet Corp10.22B
BBNXBeta Bionics Inc941.63M
MMEDMiniMed Group Inc5.14B
DXCMDexcom Inc29.54B
ABTAbbott Laboratories189.93B
SENSSenseonics Holdings Inc564.46M
INSPInspire Medical Systems Inc1.78B
MDTMedtronic Plc129.17B
EMBCEmbecta Corp367.44M
IRTCiRhythm Holdings Inc2.96B

Insider trading

latest 14 of 55
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
TWOMEY CHRISTOPHER JDirectorOct 27 '26Option Exercise19.001,70032,30026,134Oct 29 04:06 PM
TWOMEY CHRISTOPHER JDirectorOct 27 '26Sale19.151,70032,55524,434Oct 29 04:06 PM
CHRISTOPHER TWOMEYDirectorOct 27 '26Proposed Sale18.901,70032,130Oct 27 04:29 PM
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerOct 15 '26Option Exercise0.003,637033,927Oct 19 06:20 PM
MARK NOVARAOfficerSep 17 '26Proposed Sale17.533606,311Sep 17 04:32 PM
Vosseller LeighEVP & CHIEF FINANCIAL OFFICERAug 15 '26Option Exercise0.004,120052,982Aug 18 04:28 PM
Sheridan John FPRESIDENT & CEOAug 15 '26Option Exercise0.0015,9160165,315Aug 18 04:28 PM
Morrison SusanEVP & Chief Admin. OfficerAug 15 '26Option Exercise0.002,827053,283Aug 18 04:28 PM
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerAug 15 '26Option Exercise0.001,010030,825Aug 18 04:27 PM
Gasser Elizabeth AnneEVP, Chief Strategy OfficerAug 15 '26Option Exercise0.003,01402,425Aug 18 04:27 PM
Carpenter RickEVP & Chief Technology OfficerAug 15 '26Option Exercise0.002,507032,968Aug 18 04:27 PM
Hansen Shannon MarieEVP & Chief Legal OfficerAug 15 '26Option Exercise0.003,014032,626Aug 18 04:26 PM
MARK NOVARAOfficerAug 18 '26Proposed Sale22.261312,915Aug 18 04:23 PM
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerJul 15 '26Option Exercise0.003,636031,741Jul 17 04:07 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 206
  • Tandem Diabetes Care names next CEO (MedTech Dive) -6.00%
  • Tandem Diabetes Care Delivers A Clean Q3 Beat, But A Softer 2027 Framing And Slower Pharmacy Shift Undercut The Upside (Earnings Whispers) -5.56%
  • Tandem Diabetes Care Names Jeannette Bankes as President and Chief Executive Officer (Business Wire)
  • Tandem Diabetes Care Announces Upcoming Conference Presentations (Business Wire)
  • Tandem Faces A Proof Point On Pharmacy Shift As Mobi Tubeless Launch Nears (Earnings Whispers)
  • Loading…
  • Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls (The Fly)
  • Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026 (Business Wire)
  • Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets (Business Wire)
  • MiniMed submits new patch pump for FDA clearance (MedTech Dive)
  • Nvidia initiated, Teradyne downgraded: Wall Street's top analyst calls (The Fly)
  • Tandem Diabetes Care Announces Upcoming Conference Presentation (Business Wire)
  • Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls (The Fly)
  • DXCM Grew. The Stock Did Not. Someone Is Wrong (Trefis)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.102-0.245-0.100283.69265.8421
2026Q22026-08-06-0.307-0.321-0.307254.56254.9919
2026Q12026-05-07-0.298-0.444-0.298247.22240.4118
2025Q42026-02-19-0.009-0.093-0.009290.38277.0121
2025Q32025-11-06-0.313-0.329-0.313249.25235.7620
2025Q22025-08-06-0.482-0.399-0.782240.68238.5820
2025Q12025-04-30-0.669-0.605-1.966234.42220.3216
2024Q42025-02-260.010-0.2040.011252.45250.5817
2024Q32024-11-06-0.350-0.407-0.355242.93224.1420
2024Q22024-08-01-0.470-0.542-0.474221.76205.6315
2024Q12024-05-02-0.650-0.761-0.654192.8174.5215
2023Q42024-02-21-0.460-0.270-0.459196.8203.4914
2023Q32023-11-01-0.510-0.479-0.506185.62192.7615
2023Q22023-08-03-0.550-0.499-0.552195.92197.6214
2023Q12023-05-03-1.920-0.539-1.919171.41170.3113
2022Q42023-02-22-0.250-0.081-0.246220.522113

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.420-0.515-0.423362.31363.13
2020FY-0.630-0.716-0.564498.83472.1
2021FY0.2400.3030.242702.8691.83
2022FY-1.470-1.088-1.475801.22802
2023FY-3.430-3.211-3.426772.8764.45
2024FY-1.470-1.689-1.467909.95908.03
2025FY-1.460-2.085-3.0401,0151,001
2026FY--0.604--1,077
2027FY-0.044--1,158
2028FY-0.730--1,318
2029FY-1.379--1,469
2030FY-1.872--1,641

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1022020292.46287.15300.2
2026Q4S2026-11-0622019293.09287.15306.64
2026Q4S2026-11-052210304.35292.27315
2026Q4S2026-10-262210304.35292.27315
2026Q4S2026-10-212210304.35292.27315
2026Q4S2026-10-132261304.35292.27315
2026Q4S2026-10-122261304.36292.27315
2026Q4S2026-10-092261304.37292.27315
2026Q4S2026-09-302261304.35292.27315
2026Q4S2026-09-292261304.09292.27315
2026Q4S2026-09-232261304.08292.27315
2026Q4S2026-08-202261304.08292.27315
2026Q4S2026-08-192261304.08292.27315
2026Q4S2026-08-072162303.97292.27315

Estimate history

EPS, annual-12.865-2.548-0.423-0.5640.242-1.475-3.426-1.467-3.042-0.7153
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.3550.011-1.966-0.782-0.313-0.009-0.298-0.307-0.102
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual107.601183.866362.305498.83702.799801.217747.718940.2031015.351074.78
Period201720182019202020212022202320242025TTM
Sales, quarterly243.971282.648234.422240.678249.253290.323247.282254.14283.03
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual10.11957.55459.39662.33563.83364.51365.55266.26468.29169.757
Period201720182019202020212022202320242025MRQ
Shares, quarterly65.64666.26466.56867.53167.77368.29168.50469.5469.757
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,074.781,015.35940.20747.72801.22702.80498.83362.31183.87
Cost of Goods Sold Incl. D&A466.40483.89465.34393.84400.56338.23244.54173.8794.04
Gross Profit608.37531.46474.87353.88400.66364.57254.28188.4489.82
Selling, General and Administrative Excl. Other634.75608.97573.99508.36462.46341.92262.24205.16134.45
Research and Development187.88174.84184.17155.85126.7880.4154.3239.4329.23
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-26.38-77.51-99.13-154.48-61.8122.65-7.96-16.72-44.63
Interest Expense9.037.917.429.886.216.0412.800.087.58
Unusual Expense0.00109.141.2778.7530.891.3917.0911.0771.81
Net Income Before Taxes-43.55-200.27-91.87-220.25-92.8515.90-36.28-24.60-122.56
Income Taxes5.694.444.162.361.740.34-1.900.150.05
Consolidated Net Income-49.23-204.71-96.03-222.61-94.5915.57-34.38-24.75-122.61
Net Income From Continuing Operations-49.23-204.71-96.03-222.61-94.5915.57-34.38-24.75-122.61
Net Income-49.23-204.71-96.03-222.61-94.5915.57-34.38-24.75-122.61
EPS (Recurring)-0.71-1.91-1.45-2.58-1.140.26-0.37-0.29-1.50
EPS (Basic, Before Extraordinaries)-0.72-3.04-1.47-3.43-1.470.25-0.56-0.42-2.55
EPS (Diluted)-0.72-3.04-1.47-3.43-1.470.24-0.56-0.42-2.55
EBITDA-8.40-59.84-82.52-138.76-47.4836.502.49-10.65-38.81
Non-Operating Income (Expense)-8.13-5.7215.9422.866.060.671.573.271.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense53.2572.9880.0969.5867.0944.3542.6542.3918.75
Price To Earnings Ratio-----644.35---
Price To Sales Ratio1.061.462.512.573.6013.7811.709.639.94
Gross Margin56.6052.3450.5147.3350.0151.8750.9852.0148.85
Operating Margin-2.45-7.63-10.54-20.66-7.713.22-1.60-4.62-24.27
Net Margin-4.58-20.16-10.21-29.77-11.812.21-6.89-6.83-66.68
Shares Outstanding69.7668.2966.2665.5564.5163.8362.3459.4057.55
Market Capitalization1,305.841,305.842,365.671,928.902,890.239,562.945,950.783,522.532,178.30

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue283.03254.14247.28290.32249.25240.68234.42282.65
Cost of Goods Sold Incl. D&A123.27109.78110.43122.92114.96114.82116.02125.19
Gross Profit159.76144.36136.85167.40134.29125.86118.41157.46
Selling, General and Administrative Excl. Other162.79158.57154.22159.17154.35157.71164.07158.04
Research and Development48.8546.9346.0346.0747.8848.1250.2252.20
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.03-14.21-17.378.23-20.06-31.86-45.66-0.58
Interest Expense2.312.452.202.082.062.541.861.86
Unusual Expense0.000.000.000.002.8019.9575.220.00
Net Income Before Taxes-7.69-20.66-19.884.68-25.14-57.72-122.090.02
Income Taxes-0.610.510.525.27-3.98-5.328.47-0.74
Consolidated Net Income-7.08-21.17-20.39-0.59-21.16-52.40-130.560.76
Net Income From Continuing Operations-7.08-21.17-20.39-0.59-21.16-52.40-130.560.76
Net Income-7.08-21.17-20.39-0.59-21.16-52.40-130.560.76
EPS (Recurring)-0.10-0.31-0.30-0.01-0.28-0.57-1.170.01
EPS (Basic, Before Extraordinaries)-0.10-0.31-0.30-0.01-0.31-0.78-1.970.01
EPS (Diluted)-0.10-0.31-0.30-0.01-0.31-0.78-1.970.01
EBITDA1.48-9.74-12.8712.73-15.57-27.49-41.353.66
Non-Operating Income (Expense)-2.36-4.00-0.30-1.48-0.21-3.380.652.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.5612.4412.3715.8916.7020.2620.1422.25
Price To Sales Ratio1.061.001.281.470.821.251.292.53
Gross Margin56.4556.8055.3457.6653.8852.2950.5155.71
Operating Margin-1.07-5.59-7.032.84-8.05-13.24-19.48-0.21
Net Margin-2.50-8.33-8.25-0.20-8.49-21.77-55.690.27
Shares Outstanding69.7669.5468.5068.2967.7767.5366.5766.26
Market Capitalization1,305.841,034.101,309.811,490.30820.291,241.561,273.632,365.67

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments292.67438.33467.91616.90623.81484.94176.46129.0314.18
Short Term Receivables165.49114.58105.56114.72110.7282.1946.5935.1920.79
Inventories128.77149.61157.94111.1268.5563.7249.0719.9026.99
Other Current Assets31.2221.9616.597.248.436.384.033.772.19
Total Current Assets618.14724.49747.99849.98811.52637.24276.14187.8864.16
Net Property, Plant & Equipment179.75163.46164.33179.1877.8969.8048.4817.1519.63
Total Investments and Advances60.3574.5510.100.000.000.000.000.0010.00
Intangible Assets11.720.932.784.636.648.800.781.131.46
Other Assets11.154.2427.4619.009.090.580.710.130.10
Total Assets881.11967.66952.661,052.79905.14716.41326.11206.2995.35
Short Term Debt Incl. Current Port. of LT Debt24.3758.8817.0613.129.289.426.320.000.00
Accounts Payable47.0744.7349.5955.7328.0317.8017.756.825.15
Other Current Liabilities171.28143.44128.6196.4494.5576.6375.3359.4630.93
Total Current Liabilities242.72247.05195.26165.29131.86103.8599.4066.2936.09
Long Term Debt425.00414.69398.61406.76305.39218.9014.060.0076.54
Provision for Risks Charges22.040.0019.0419.2617.320.000.000.000.00
Other Liabilities36.1742.8226.1221.5417.4527.3617.678.7311.87
Total Liabilities725.94704.56639.03612.84472.02350.11131.1375.02124.49
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity155.17263.10313.63439.95433.11366.31194.98131.28-29.15
Total Shareholders Equity155.17263.10313.63439.95433.11366.31194.98131.28-29.15
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity155.17263.10313.63439.95433.11366.31194.98131.28-29.15
Total Liabilities & Stockholders Equity881.11967.66952.661,052.79905.14716.41326.11206.2995.35
Book Value Per Share2.273.974.786.826.795.883.282.28-2.88
Tangible Book Value Per Share2.103.964.746.756.685.743.272.26-3.02
Full-Time Employees2,5002,6502,4002,6002,0001,5001,043653574
Price to Book Ratio9.669.956.146.8522.1816.2818.1616.65-0.46
Return on Assets-22.15-10.00-22.20-9.661.92-6.60-9.30-81.30-70.31
Return on Equity-97.88-33.30-59.08-21.673.89-12.25-15.17-240.11-
Return on Invested Capital-35.28-14.17-31.26-11.172.11-5.88-11.84-93.40-154.10
Quick Ratio2.022.333.024.475.635.522.282.531.03
Current Ratio2.552.933.835.146.156.142.782.831.78

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-49.23-204.71-96.03-222.61-94.5915.57-34.38-24.75-122.61
Depreciation17.9817.6716.6115.7114.3313.8510.456.075.82
Other Funds (Non Cash)103.01200.36115.42192.77135.3867.5887.3172.94100.01
Funds from Operations71.7613.3236.01-14.1255.1196.9961.2654.25-16.78
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-86.36-23.04-11.78-17.68-4.6514.37-36.59-12.358.46
Cash from Operating Activities-14.61-9.7224.23-31.8150.46111.3624.6741.91-8.32
Capital Expenditures-21.69-19.95-19.23-26.80-34.10-23.51-32.29-19.54-2.99
Net Assets From Acquisitions43.460.000.00-69.50-25.720.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-141.53171.4142.1535.36101.84-163.37-263.76-37.41-87.75
Purchase of Investments-320.13-85.66-264.31-510.86-467.65-733.39-497.08-164.57-123.55
Sale Or Maturity of Investments178.60257.07306.46546.22569.49570.02233.31127.1635.80
Other Uses-160.01-78.59-46.40-24.80-8.860.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-279.7772.88-23.48-85.7433.17-186.88-296.06-56.95-90.74
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.60-2.61-36.734.1817.5551.9369.8224.21204.90
Repurchase of Common Pref Stock0.000.00-30.000.000.000.000.000.000.00
Sale of Common Pref Stock2.60-2.61-6.734.1817.5551.9369.8224.21204.90
Proceedsfrom Stock Options2.60-2.610.004.1817.4751.3466.8723.88175.32
Issuance or Reduction of Debt, Net271.36-40.7644.910.000.000.00244.620.00-87.71
Change in Long Term Debt271.36-40.7644.910.000.000.00244.620.00-87.71
Issuance of Long Term Debt291.160.00306.850.000.000.00278.690.000.00
Reduction of Long Term Debt-19.80-40.76-261.940.000.000.00-34.070.00-87.71
Net Financing Active Other Cash Flow-2.080.000.18-0.07-0.680.000.000.000.00
Other Financing Activities Uses-2.080.000.00-0.07-0.680.000.000.000.00
Cash from Financing Activities271.89-43.378.374.1116.8851.93314.4424.21117.18
Exchange Rate Effect3.391.611.26-0.210.830.150.390.19-
Net Change in Cash-19.1121.4010.37-113.65101.34-23.4343.449.3518.13
Free Cash Flow-36.30-29.674.99-58.6116.3797.18-2.7422.36-11.30
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow--472.08-176.1799.67-155.95-
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.00-2.130.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments443.08456.00570.26292.67319.11315.36
Short Term Receivables180.02162.06140.67165.49125.94128.44
Inventories143.12135.11126.40128.77137.28142.57
Other Current Assets54.5051.4749.7731.2234.6128.44
Total Current Assets820.72804.64887.10618.14616.94614.82
Net Property, Plant & Equipment183.14184.69178.99179.75176.28175.95
Total Investments and Advances125.54132.2756.4960.3564.9067.63
Intangible Assets---11.72--
Other Assets30.0932.6130.8211.1516.5217.34
Total Assets1,159.491,154.201,153.39881.11874.65875.74
Short Term Debt Incl. Current Port. of LT Debt20.3820.2720.1124.3721.3419.89
Accounts Payable74.8064.1359.8647.0747.4855.84
Other Current Liabilities160.89168.61167.99171.28183.72175.96
Total Current Liabilities256.07253.00247.96242.72252.54251.69
Long Term Debt716.16718.99714.63425.00427.94429.12
Provision for Risks Charges21.890.0021.9222.040.0021.55
Other Liabilities30.2851.8236.4836.1761.2040.09
Total Liabilities1,024.411,023.811,020.99725.94741.69742.45
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity135.09130.39132.40155.17132.97133.28
Total Shareholders Equity135.09130.39132.40155.17132.97133.28
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity135.09130.39132.40155.17132.97133.28
Total Liabilities & Stockholders Equity1,159.491,154.201,153.39881.11874.65875.74
Book Value Per Share1.941.881.932.271.961.97
Tangible Book Value Per Share1.941.881.932.101.961.97
Full-Time Employees---2,500--
Price to Book Ratio9.667.818.4411.206.157.99
Return on Assets-4.84-6.24-9.11-22.15-22.20-22.66
Return on Equity-36.74-48.03-65.73-97.88-109.73-111.91
Return on Invested Capital-0.83-2.49-2.41-0.10-3.77-9.32
Quick Ratio2.652.653.072.021.901.88
Current Ratio3.213.183.582.552.442.44

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-7.08-21.17-20.39-0.59-21.16-52.40
Depreciation4.514.474.504.504.494.37
Other Funds (Non Cash)26.7623.5723.2729.4227.7929.37
Funds from Operations24.196.877.3833.3311.12-18.66
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-25.01-41.503.68-23.54-2.859.16
Cash from Operating Activities-0.82-34.6311.059.798.26-9.50
Capital Expenditures-4.69-4.05-6.27-6.68-4.09-6.21
Net Assets From Acquisitions0.000.000.0043.460.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments22.67-1.86-189.1826.8324.6364.34
Purchase of Investments-29.97-44.38-216.13-29.66-29.51-17.05
Sale Or Maturity of Investments52.6442.5226.9556.4954.1481.38
Other Uses0.00-81.430.00-78.590.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities17.98-87.34-195.45-14.9820.5458.13
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.001.70-1.702.60-1.571.05
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.001.70-1.702.60-1.571.05
Proceedsfrom Stock Options0.001.70-1.702.60-1.57-3.64
Issuance or Reduction of Debt, Net-4.500.00275.860.000.00-40.76
Change in Long Term Debt-4.500.00275.860.000.00-40.76
Issuance of Long Term Debt0.000.00291.160.000.000.00
Reduction of Long Term Debt-4.500.00-15.300.000.00-40.76
Net Financing Active Other Cash Flow-2.530.460.000.000.000.00
Other Financing Activities Uses-2.080.000.000.000.000.00
Cash from Financing Activities-7.032.15274.162.60-1.57-39.71
Exchange Rate Effect-0.113.31-1.081.270.601.62
Net Change in Cash10.02-116.5188.69-1.3127.8410.54
Free Cash Flow-5.51-38.684.793.104.17-15.70

Revenue breakdown

Pump2024: 434.17M 2025: 464.14M
Supplies and Other2024: 475.79M 2025: 550.60M
Tandem Choice Program, Recognized (Deferred)2024: 30.25M
Non-US2024: 267.52M 2025: 307.80M
United States2024: 672.69M 2025: 706.94M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3023.46%16.2M68.9M2.13M
2026-10-1521.95%15.1M68.7M2.06M
2026-09-3019.45%13.4M68.7M1.94M
2026-09-1518.15%12.5M68.7M1.89M
2026-08-3117.10%11.8M68.7M2.07M
2026-08-1415.40%10.6M68.7M2.36M
2026-07-3117.44%11.2M64.5M2.39M
2026-07-1520.65%13.1M63.5M2.38M
2026-06-3020.05%12.7M63.5M2.37M
2026-06-1517.09%10.9M63.5M2.34M
2026-05-2918.61%11.8M63.3M2.19M
2026-05-1517.05%10.8M63.3M2.46M
2026-04-3015.33%9.7M63.4M2.08M
2026-04-1514.23%9.6M67.8M2.05M
2026-03-3115.58%10.5M67.6M2.02M
2026-03-1315.61%10.5M67.6M1.86M
2026-02-2714.45%9.8M67.6M1.85M
2026-02-1313.26%9.0M67.6M1.59M
2026-01-3013.31%8.9M67.1M1.89M
2026-01-1513.42%9.0M67.1M1.89M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call3.0014.7016.900.009.3740.000.000.994-0.0180.001
call4.0013.7017.100.0012.0560.000.000.988-0.0300.001
call5.0012.7016.100.0010.8610.000.000.985-0.0310.001
call6.0011.7013.900.005.8960.000.000.983-0.0310.001
call7.0010.7013.000.005.4990.000.000.980-0.0300.001
call8.0010.0011.900.004.5830.000.000.977-0.0300.002
call9.009.2010.900.004.0570.000.000.974-0.0300.002
call10.008.2010.000.003.6280.000.000.971-0.0290.002
call11.007.208.906.502.9570.000.000.967-0.0290.002
call12.006.207.903.902.7814.000.000.962-0.0280.003
call13.005.306.904.502.4555.000.000.956-0.0270.003
call14.003.805.905.602.11611.000.000.948-0.0260.003
call15.003.005.002.001.7899.000.000.826-0.0970.008
call16.001.754.103.801.6913310.000.795-0.0900.009
call17.001.453.102.101.38362.000.000.755-0.0810.010
call18.001.002.150.831.0881980.000.693-0.0750.011
call19.000.951.600.701.1379190.000.588-0.1180.012
call20.000.500.900.600.9373151.000.496-0.0980.012
call21.000.000.750.151.10093.000.000.378-0.0780.012
call22.000.000.750.501.3411770.000.315-0.0810.011
call23.000.050.750.501.52257.000.000.288-0.0890.010
call24.000.000.752.551.7075.000.000.267-0.0960.010
call25.000.000.750.901.9191,5380.000.248-0.1030.010
call26.000.000.750.252.05341.000.000.236-0.1080.009
call27.000.000.750.152.19214.000.000.225-0.1120.009
call28.000.000.751.172.34432.000.000.216-0.1170.009
call29.000.000.751.052.4161.000.000.180-0.1050.008
call30.000.000.300.151.9941030.000.114-0.0660.006
call31.000.000.750.852.0992.000.000.110-0.0670.006
call32.000.000.750.802.20319.000.000.106-0.0690.006
call33.000.000.750.502.28825.000.000.103-0.0700.006
call34.000.000.750.772.3784.000.000.100-0.0710.005
call35.000.000.750.152.49984.000.000.097-0.0730.005
call36.000.000.750.622.5626.000.000.095-0.0740.005
call37.000.000.750.552.6441.000.000.093-0.0750.005
call38.000.000.750.002.7270.000.000.091-0.0760.005
call39.000.000.750.002.7870.000.000.089-0.0770.005
call40.000.000.750.002.8600.000.000.087-0.0780.005
put3.000.000.050.005.5260.000.00-0.007-0.0160.001
put4.000.000.750.005.5820.000.00-0.012-0.0300.001
put5.000.000.750.004.8180.000.00-0.014-0.0300.001
put6.000.000.750.004.2070.000.00-0.017-0.0300.001
put7.000.000.750.203.6971.000.00-0.019-0.0300.001
put8.000.000.750.363.24013.000.00-0.022-0.0290.002
put9.000.000.750.272.85410.000.00-0.025-0.0290.002
put10.000.000.750.502.4939.000.00-0.029-0.0280.002
put11.000.000.750.802.1794.000.00-0.034-0.0270.002
put12.000.000.750.051.8923940.00-0.038-0.0270.003
put13.000.000.750.351.6281210.00-0.044-0.0260.003
put14.000.000.100.051.37724.003.00-0.052-0.0250.003
put15.000.000.751.802.1792,1610.00-0.176-0.0950.008
put16.000.000.750.471.85461.000.00-0.203-0.0880.009
put17.000.000.752.551.51869.000.00-0.241-0.0800.010
put18.000.000.853.331.2521,5120.00-0.308-0.0730.011
put19.000.402.402.352.18527.000.00-0.411-0.1160.012
put20.000.353.202.552.3675.000.00-0.504-0.0960.012
put21.001.603.605.532.1802.000.00-0.622-0.0760.012
put22.002.403.806.501.8282.000.00-0.681-0.0780.011
put23.003.204.803.302.07011.000.00-0.711-0.0860.011
put24.004.105.800.002.2100.000.00-0.736-0.0940.010
put25.005.006.900.002.4900.000.00-0.752-0.1000.010
put26.006.007.700.002.4920.000.00-0.765-0.1050.009
put27.007.008.900.002.8300.000.00-0.776-0.1100.009
put28.008.109.900.003.0550.000.00-0.785-0.1140.009
put29.009.1010.907.403.1280.000.00-0.793-0.1180.009
put30.0010.1012.400.003.8090.000.00-0.886-0.0620.006
put31.0010.9013.400.003.8840.000.00-0.890-0.0640.006
put32.0011.9014.400.003.9940.000.00-0.894-0.0650.006
put33.0012.9015.400.004.1150.000.00-0.897-0.0670.005
put34.0013.9016.400.004.2310.000.00-0.900-0.0680.005
put35.0014.8017.400.004.3420.000.00-0.903-0.0690.005
put36.0015.9018.400.004.4480.000.00-0.905-0.0700.005
put37.0016.9019.400.004.5500.000.00-0.907-0.0710.005
put38.0018.0020.400.004.6480.000.00-0.909-0.0720.005
put39.0018.7021.400.004.7420.000.00-0.911-0.0730.005
put40.0019.9022.300.004.7360.000.00-0.913-0.0730.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-09SCHEDULE 13GSEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-27144Filing for proposed sale of securities under Rule 144.SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-09-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-06SCHEDULE 13G/ASEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-06-17144Filing for proposed sale of securities under Rule 144.SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-27S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100032.56K1
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-03004.36K2
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.16.90%
Sessa Capital IM, L.P.7.44%
VANGUARD PORTFOLIO MANAGEMENT LLC6.27%
First Light Asset Management, LLC4.94%
VANGUARD CAPITAL MANAGEMENT LLC4.52%
GW&K Investment Management, LLC4.17%
STATE STREET CORP4.16%
JENNISON ASSOCIATES LLC3.40%
UBS Group AG3.16%
JACOBS LEVY EQUITY MANAGEMENT, INC2.93%

Funds

Fund% owned
iShares Convertible Bond ETF10.25%
iShares Core S&P Small-Cap ETF6.03%
Virtus Convertible & Income Fund4.87%
Virtus Convertible & Income Fund II3.88%
Virtus Dividend, Interest & Premium Strategy Fund3.88%
Virtus Equity & Convertible Income Fund3.86%
AQR Diversified Arbitrage Fund3.25%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.19%
Fidelity Convertible Securities Fund3.14%
WESTWOOD ALTERNATIVE INCOME FUND2.92%

OakChart. TNDM. Cached 15 minutes.

Some panels did not load: dv.